Brief: Opgen's Subsidiary Ares Genetics Provides Update On Collaboration Agreement To Drive Cutting-Edge Digital Solutions In Global Fight Against Antimicrobial Resistance
06/04/2022 12:34
April 6 (Reuters) - OpGen Inc OPGN.O :
* OPGEN’S SUBSIDIARY ARES GENETICS PROVIDES UPDATE ON
COLLABORATION AGREEMENT TO DRIVE CUTTING-EDGE DIGITAL SOLUTIONS
IN GLOBAL FIGHT AGAINST ANTIMICROBIAL RESISTANCE (AMR)
* OPGEN INC- XTENDED EXISTING MASTER SERVICES AGREEMENT WITH
SANDOZ TO JANUARY 31, 2025
Source text for Eikon: ID:nGNX7gh0zm
Further company coverage: OPGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CapForce
See all newsBrief: Opgen Says Financial Statements Contained Within Quarterly Report On Form 10-Q For Q1 2024 Should No Longer Be Relied Upon
Brief: Opgen Inc - Received Nasdaq Notice That Co Is Not In Compliance With Minimum Stockholders' Equity Requirement For Continued Listing
Brief: OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
Brief: OpGen Announces 1-For-10 Reverse Stock Split
Brief: David E. Lazar Reports 19.9% Stake In Opgen Inc As Of March 25- SEC Filing